These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2103524)

  • 1. Fundus changes in chronic membranoproliferative glomerulonephritis type II.
    Michielsen B; Leys A; Van Damme B; Missotten L
    Doc Ophthalmol; 1990-1991; 76(3):219-29. PubMed ID: 2103524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.
    Ulbig MR; Riordan-Eva P; Holz FG; Rees HC; Hamilton PA
    Am J Ophthalmol; 1993 Oct; 116(4):410-3. PubMed ID: 8213970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II.
    Leys A; Michielsen B; Leys M; Vanrenterghem Y; Missotten L; Van Damme B
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):499-504. PubMed ID: 2265764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients.
    Leys A; Vanrenterghem Y; Van Damme B; Snyers B; Pirson Y; Leys M
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):406-10. PubMed ID: 1937071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings.
    Duvall-Young J; Short CD; Raines MF; Gokal R; Lawler W
    Br J Ophthalmol; 1989 Nov; 73(11):900-6. PubMed ID: 2605144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior segment changes in membranoproliferative glomerulonephritis.
    Kim DD; Mieler WF; Wolf MD
    Am J Ophthalmol; 1992 Nov; 114(5):593-9. PubMed ID: 1443022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal function abnormalities in membranoproliferative glomerulonephritis type II.
    Kim RY; Faktorovich EG; Kuo CY; Olson JL
    Am J Ophthalmol; 1997 May; 123(5):619-28. PubMed ID: 9152067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular impairment during type II membranoproliferative glomerulonephritis].
    Lahbil D; Rais L; Hamdani M; El Kettani A; Laouissi N; Zaghloul K; Amraoui A
    J Fr Ophtalmol; 2002 Nov; 25(9):949-54. PubMed ID: 12515943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundus changes in type III membranoproliferative glomerulonephritis: a case report.
    Takei M; Obana A; Inomata T; Tanaka T; Shiang T; Bae Y; Takemura T; Murakami A
    BMC Ophthalmol; 2018 Mar; 18(1):72. PubMed ID: 29510686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential observation of fundus changes in patients with long standing membranoproliferative glomerulonephritis type II (MPGN type II).
    Leys A; Vanrenterghem Y; Van Damme B; Snyers B; Pirson Y; Leys M
    Eur J Ophthalmol; 1991; 1(1):17-22. PubMed ID: 1821193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities.
    O'Brien C; Duvall-Young J; Brown M; Short C; Bone M
    Br J Ophthalmol; 1993 Dec; 77(12):778-80. PubMed ID: 8110672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report.
    Duvall-Young J; MacDonald MK; McKechnie NM
    Br J Ophthalmol; 1989 Apr; 73(4):297-302. PubMed ID: 2713310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microperimetric evaluation of macula in retinopathy of membranoproliferative glomerulonephritis type II: a case report.
    Shenoy R; McCilvenny S
    Eur J Ophthalmol; 2006; 16(4):634-6. PubMed ID: 16952110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choroidal neovascularisation in type II membranoproliferative glomerulonephritis, photodynamic therapy as a treatment option--a case report].
    Hassenstein A; Richard G
    Klin Monbl Augenheilkd; 2003 Jul; 220(7):492-5. PubMed ID: 12886510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term fundus changes in acquired partial lipodystrophy.
    Jansen J; Delaere L; Spielberg L; Leys A
    BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24248317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retinochoroidal involvement of type II membranoproliferative glomerulonephritis. An angiographic study with indocyanine green].
    Parrat E; Arndt CF; Labalette P; Boulanger E; Hache JC; Constantinides G; Dequiedt P
    J Fr Ophtalmol; 1997; 20(6):430-8. PubMed ID: 9296039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long history of dense deposit disease.
    Cunningham A; Kotagiri A
    BMC Ophthalmol; 2018 Sep; 18(Suppl 1):228. PubMed ID: 30255792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease").
    Colville D; Guymer R; Sinclair RA; Savige J
    Am J Kidney Dis; 2003 Aug; 42(2):E2-5. PubMed ID: 12900843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dense deposit disease is not a membranoproliferative glomerulonephritis.
    Walker PD; Ferrario F; Joh K; Bonsib SM
    Mod Pathol; 2007 Jun; 20(6):605-16. PubMed ID: 17396142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II].
    Framme C; Herboth T; Roider J; Laqua H
    Klin Monbl Augenheilkd; 1998 Oct; 213(4):252-3. PubMed ID: 9848073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.